BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21223801)

  • 1. [Comparison of touch imprint cytology of core needle biopsy and section histopathology in breast cancer diagnosis].
    Zhang ZH; Zhao LL; Guo HQ; Zheng S; Zhang BL; Xu XZ; Pan QJ; Zhang BN
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):921-6. PubMed ID: 21223801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions.
    Klevesath MB; Godwin RJ; Bannon R; Munthali L; Coveney E
    Eur J Surg Oncol; 2005 Jun; 31(5):490-4. PubMed ID: 15922884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy.
    Khoury T; Zakharia Y; Tan W; Kulkarni S; Liu W; Zhang S; Wilding GE; Edge S
    Breast J; 2011; 17(2):180-6. PubMed ID: 21306471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women.
    Ballo MS; Sneige N
    Cancer; 1996 Aug; 78(4):773-7. PubMed ID: 8756371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
    Chen X; Yuan Y; Gu Z; Shen K
    Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
    Radhika K; Prayaga AK
    Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with percutaneus large-core needle biopsies of the breast and evaluation of cytopathological and histopathological results].
    Anlauf M; Nicklaus S; Rode G; Jäckel C; Neumann K; Kalbfleisch H; Mühlberger G
    Zentralbl Gynakol; 2003 Sep; 125(9):353-61. PubMed ID: 14569517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of accuracy of diagnostic modalities for evaluation of breast cancer with review of literature.
    Bukhari MH; Akhtar ZM
    Diagn Cytopathol; 2009 Jun; 37(6):416-24. PubMed ID: 19217034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasound-guided core needle biopsy in the diagnosis of breast lesions].
    Fan ZQ; Ouyang T; Wang TF; Li JF; Xie YT; Fan T; Zhang Z; Lin BY
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1185-7. PubMed ID: 18067713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens].
    Zhang Z; Zhao L; Guo H; Guo L; Ling Y; Xu X; Zhao H; Pan Q
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):183-7. PubMed ID: 24785277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cytological and histological diagnosis of breast lesions: A critical review.
    Kooistra B; Wauters C; Strobbe L; Wobbes T
    Eur J Surg Oncol; 2010 Oct; 36(10):934-40. PubMed ID: 20709485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy.
    Kasami M; Uematsu T; Honda M; Yabuzaki T; Sanuki J; Uchida Y; Sugimura H
    Breast; 2008 Oct; 17(5):523-7. PubMed ID: 18534850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions.
    Wauters CA; Sanders-Eras MC; de Kievit-van der Heijden IM; Wesseling P; Venderink DJ; van Dijk Azn R; van den Wildenberg F; Kooistra BW; Strobbe LJ
    Eur J Surg Oncol; 2010 Oct; 36(10):957-62. PubMed ID: 20708371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of vacuum-assisted stereotactic core needle biopsy for breast lesions.
    Wiratkapun C; Fusuwankaya E; Wibulpholprasert B; Lertsittichai P
    J Med Assoc Thai; 2010 Sep; 93(9):1058-64. PubMed ID: 20873078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Touch imprint cytology of core needle biopsy specimens for the breast and quick stain procedure for immediate diagnosis.
    Kehl S; Mechler C; Menton S; Weiss C; Wasgindt S; Sütterlin M; Trunk M
    Anticancer Res; 2014 Jan; 34(1):153-7. PubMed ID: 24403456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
    Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
    Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.